MyMD Pharmaceuticals, Inc.
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityMYMD / MyMD Pharmaceuticals, Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership19 shares
Latest Disclosed Value $ 66
BlackRock, Inc. ownership in MYMD / MyMD Pharmaceuticals, Inc.

On May 13, 2026 - BlackRock, Inc. filed a 13F-HR form disclosing ownership of 19 shares of MyMD Pharmaceuticals, Inc. (US:MYMD) valued at $66 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 19 shares of MyMD Pharmaceuticals, Inc.. The current value of the position is $35 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F Q COM 62856X300 19 0 0.00 0 0.0000
2026-02-12 2025-12-31 13F Q COM 62856X300 19 0 0.00 0 0.0000
2025-11-12 2025-09-30 13F Q COM 62856X300 19 19 0 0.0000
2024-05-10 2024-03-31 13F MYMD PHARMACEUTICALS COM 62856X102 0 -206,078 -100.00 0 -100.00
2024-02-13 2023-12-31 13F MYMD PHARMACEUTICALS COM 62856X102 206,078 -1,086 -0.52 53 -56.56 0.0000
2023-11-13 2023-09-30 13F MYMD PHARMACEUTICALS COM 62856X102 207,164 -3,801 -1.80 123 -61.39 0.0000
2023-08-11 2023-06-30 13F MYMD PHARMACEUTICALS COM 62856X102 210,965 6,308 3.08 316 -10.23 0.0000
2023-05-12 2023-03-31 13F MYMD PHARMACEUTICALS COM 62856X102 204,657 7,336 3.72 352 55.75 0.0000
2023-02-13 2022-12-31 13F MYMD PHARMACEUTICALS COM 62856X102 197,321 1,860 0.95 227 -55.69 0.0000
2022-11-14 2022-09-30 13F MYMD PHARMACEUTICALS COM 62856X102 195,461 -3,469 -1.74 510 18.06 0.0000
2022-08-12 2022-06-30 13F MYMD PHARMACEUTICALS COM 62856X102 198,930 -4,591 -2.26 432 -54.43 0.0000
2022-05-12 2022-03-31 13F MYMD PHARMACEUTICALS COM 62856X102 203,521 -6,979 -3.32 948 -25.71 0.0000
2022-02-10 2021-12-31 13F MYMD PHARMACEUTICALS COM 62856X102 210,500 63,867 43.56 1,276 20.83 0.0000
2021-11-09 2021-09-30 13F MYMD PHARMACEUTICALS COM 62856X102 146,633 43,588 42.30 1,056 62.46 0.0000
2021-08-11 2021-06-30 13F MYMD PHARMACEUTICALS COM 62856X102 103,045 96,194 1,404.09 650 2,854.55 0.0000
2021-05-07 2021-03-31 13F AKERS BIOSCIENCES COM 00973E409 6,851 0 0.00 22 57.14 0.0000
2021-02-05 2020-12-31 13F AKERS BIOSCIENCES COM 00973E409 6,851 0 0.00 14 -6.67 0.0000
2020-11-06 2020-09-30 13F AKERS BIOSCIENCES COM 00973E409 6,851 -1 -0.01 15 -37.50 0.0000
2020-08-14 2020-06-30 13F AKERS BIOSCIENCES COM 00973E409 6,852 0 0.00 24 60.00 0.0000
2020-05-01 2020-03-31 13F AKERS BIOSCIENCES COM 00973E409 6,852 0 0.00 15 -31.82 0.0000
2020-02-13 2019-12-31 13F AKERS BIOSCIENCES COM 00973E409 6,852 -157,625 -95.83 22 -69.44 0.0000
2019-11-08 2019-09-30 13F AKERS BIOSCIENCES COM NEW 00973E300 164,477 0 0.00 72 -2.70 0.0000
2019-08-22 2019-06-30 13F/A-1 AKERS BIOSCIENCES COM NEW 00973E300 164,477 1 0.00 74 -53.46 0.0000
2019-08-13 2019-06-30 13F AKERS BIOSCIENCES COM NEW 00973E300 164,477 1 74
2019-05-09 2019-03-31 13F AKERS BIOSCIENCES COM NEW 00973E300 164,476 0 0.00 159 -14.52 0.0000
2019-02-08 2018-12-31 13F AKERS BIOSCIENCES COM NEW 00973E300 164,476 -1,151,339 -87.50 186 -50.13 0.0000
2018-11-09 2018-09-30 13F AKERS BIOSCIENCES COM 00973E102 1,315,815 0 0.00 373 -26.72 0.0000
2018-08-09 2018-06-30 13F AKERS BIOSCIENCES COM 00973E102 1,315,815 1,300,405 8,438.71 509 3,815.38 0.0000
2018-05-09 2018-03-31 13F AKERS BIOSCIENCES COM 00973E102 15,410 0 0.00 13 550.00 0.0000
2018-02-09 2017-12-31 13F AKERS BIOSCIENCES COM 00973E102 15,410 0 0.00 2 -84.62 0.0000
2017-11-14 2017-09-30 13F AKERS BIOSCIENCES COM 00973E102 15,410 0 0.00 13 -31.58 0.0000
2017-08-10 2017-06-30 13F AKERS BIOSCIENCES COM 00973E102 15,410 662 4.49 19 -26.92 0.0000
2017-05-12 2017-03-31 13F AKERS BIOSCIENCES COM 00973E102 14,748 14,748 26 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.